83 related articles for article (PubMed ID: 8373227)
1. [Transarterial immuno-chemotherapy including adoptive transfer of autologous cultured lymphocytes for stage IV breast cancer patients with locally-advanced tumor].
Kan N; Harada T; Kodama H; Ichinose Y; Moriguchi Y; Sugie T; Li L; Sato K; Imamura M
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1593-6. PubMed ID: 8373227
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
Kan N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
[TBL] [Abstract][Full Text] [Related]
3. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
Kan N
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
[TBL] [Abstract][Full Text] [Related]
4. [Successfully treated locally advanced breast cancer by intra-arterial infusion chemotherapy: a case report].
Suzuki N; Nakazawa H; Akiyama H
Gan To Kagaku Ryoho; 1992 Apr; 19(4):541-3. PubMed ID: 1373051
[TBL] [Abstract][Full Text] [Related]
5. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
[TBL] [Abstract][Full Text] [Related]
6. [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Ohsumi K; Kudo N; Mukaihara S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1632-5. PubMed ID: 1530322
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative intra-arterial infusion chemotherapy in locally advanced primary breast cancer-tissue concentrations of 5-fluorouracil and adriamycin, and the histological evaluation].
Ishikawa H; Murayama N; Kasahara M; Ikoma M; Takenaka Y; Yoshida H; Shimada A; Watanabe M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2911-6. PubMed ID: 3140732
[TBL] [Abstract][Full Text] [Related]
8. [Clinical experience of intra-arterial chemotherapy for liver metastases of breast cancer patients].
Tokura H; Ikeda T; Masamura S; Matsui A; Hojo T; Kawaguchi M; Takayama S; Mitsui Y; Miyabe R; Kitajima M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1780-2. PubMed ID: 11708033
[TBL] [Abstract][Full Text] [Related]
9. [A case report of the effective arterial infusion for advanced recurrence breast cancer with 5-FU, ADM, CDDP and OK-432].
Tachibana K; Furukawa M; Nakata T; Setoguchi M; Kusano T; Lin Y; Tashiro K; Suga K; Miyazaki K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2169-71. PubMed ID: 3395141
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
11. [Intra-arterial chemotherapy in locally advanced or recurrent breast neoplasms].
Morandi C; Colopi S; Cantore M; Molani L; Calzona C; Reggiani G; Amadori M; Smerieri F; Pellecchi G
Radiol Med; 1996; 92(1-2):101-4. PubMed ID: 8966246
[TBL] [Abstract][Full Text] [Related]
12. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
[TBL] [Abstract][Full Text] [Related]
13. [Loco-regional immunotherapy with OK-432 and cultured autologous lymphocytes for patients with metastatic cancer].
Kan N; Imamura M
Hum Cell; 1993 Jun; 6(2):100-5. PubMed ID: 8217947
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of stage IV breast cancer with locally advanced lesion treated by intra-arterial infusion chemotherapy using implantable reservoir].
Mukai S; Sato N; Saito M; Tamegai Y; Morikoshi E
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1972-5. PubMed ID: 1877841
[TBL] [Abstract][Full Text] [Related]
15. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
[TBL] [Abstract][Full Text] [Related]
17. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
[TBL] [Abstract][Full Text] [Related]
18. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
Blumenschein GR; DiStefano A; Caderao J; Fristenberg B; Adams J; Schweichler LH; Drinkard L
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2633-7. PubMed ID: 10068266
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
